Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism

por Xie, Lingxiang, Xiao, Yang, Tai, Shi, Yang, Huijie, Zhou, Shenghua, Zhou, Zhiguang
Publicado 2022

Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy

por Hu, Jingyi, Zhang, Rong, Zou, Hailan, Xie, Lingxiang, Zhou, Zhiguang, Xiao, Yang
Publicado 2022

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications

por Zhang, Jing, Xiao, Yang, Hu, Jingyi, Liu, Shanshan, Zhou, Zhiguang, Xie, Lingxiang
Publicado 2022

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma

por Yang, Huijie, Zhang, Weiwen, Ding, Jin, Hu, Jingyi, Sun, Yi, Peng, Weijun, Chu, Yi, Xie, Lingxiang, Mei, Zubing, Shao, Zhuo, Xiao, Yang
Publicado 2022

Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study

por Hu, Jingyi, Ding, Jin, Li, Xia, Li, Jun, Zheng, Tingting, Xie, Lingxiang, Li, Chenyu, Tang, Yingxin, Guo, Keyu, Huang, Juan, Liu, Shanshan, Yan, Jianru, Peng, Weijun, Hou, Can, Wen, Li, Xu, Aimin, Zhou, Zhiguang, Xiao, Yang
Publicado 2023